亿帆医药：根据现行会计准则，已计提的无形资产减值不允许转回

Core Viewpoint - Yifan Pharmaceutical stated that according to current accounting standards, recognized impairment of intangible assets cannot be reversed, but the company will continue to strive to further explore the market value of the product [2] Group 1 - Yifan Pharmaceutical has acknowledged the impairment of intangible assets and clarified that it cannot be reversed under existing accounting regulations [2] - The company is committed to enhancing the market value of its products despite the impairment [2]